Application of Box-Behnken design for optimization of A RP-HPLC method for determination of palonosetron and netupitant in their combined dosage form in presence of their impurities

References

• Navari, R. M. Palonosetron: A Second Generation 5-Hydroxytryptamine 3 Receptor Antagonist. Expert Opin. Drug Metab. Toxicol. 2009, 5, 1577–1586. DOI: 10.1517/17425250903407289.
   PubMed Web of Science ®Google Scholar
• De Jonghe, B. C.; Horn, C. C. Chemotherapy Agent Cisplatin Induces 48-h FOS Expression in the Brain of a Vomiting Species, the House Musk Shrew (Suncus murinus). Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 296, 902–911.
   PubMed Web of Science ®Google Scholar
• Yang, L. P. H.; Scott, L. J. Palonosetron. Drugs 2009, 69, 2257–2278. DOI: 10.2165/11200980-000000000-00000.
   PubMed Web of Science ®Google Scholar
• FDA Approves Akynzeo for Chemo-Induced Nausea and Vomiting. Oncol. Times 2014, 36, 44.
   Google Scholar
• Rizzi, A.; Campi, B.; Camarda, V.; Molinari, S.; Cantoreggi, S.; Regoli, D.; Pietra, C.; Calo, G. In Vitro and In Vivo Pharmacological Characterization of the Novel NK1 Receptor Selective Antagonist Netupitant. Peptides 2012, 37, 86–97. DOI: 10.1016/j.peptides.2012.06.010.
   PubMed Web of Science ®Google Scholar
• Zou, P.; Xie, M.-H.; Wu, H.; Liu, Y.-L.; He, Y.-J. 5,6,7,8-Tetrahydronaphthalene-1-Carboxylic Acid. Acta Crystallogr. Sect. E Struct. Rep. Online 2009, 65, 3223.
   Google Scholar
• Hoffmann, T.; Bös, M.; Stadler, H.; Schnider, P.; Hunkeler, W.; Godel, T.; Galley, G.; Ballard, T. M.; Higgins, G. A.; Poli, S. M.; Sleight, A. J. Design and Synthesis of a Novel, Achiral Class of Highly Potent and Selective, Orally Active Neurokinin-1 Receptor Antagonists. Bioorg. Med. Chem. Lett. 2006, 16, 1362–1365. DOI: 10.1016/j.bmcl.2005.11.047.
   PubMed Web of Science ®Google Scholar
• Kusuma Jogi, M. V.; Rao, B.; Rameshraju, R. A Novel Validated RP-HPLC Method for the Simultaneous Estimation of Netupitant and Palonosetron in Bulk and Pharmaceutical Dosage Form. Int. J. Curr. Sci. Techol. 2017, 5, 317–323.
   Google Scholar
• Asha, K.; Komal Jain, K. S.; Jyothirmayee Abigail, B. Simultaneous Estimation of Netupitant and Palonosetron in Its Bulk and Pharmaceutical Dosage Form by Rp-HPLC Method. J. Synth. Nat. Chem. 2016, 1, 1–6.
   Google Scholar
• Shaik, M.; Pavan, K. K. A Novel Development of RP-HPLC Method for the Estimation of Netupitant and Palonosetron in Bulk and Their Combined Dosage Form. Eur. J. Biomed. Pharm. Sci. 2019, 6, 300–304.
   Google Scholar
• Gampa Vijay Kumar, B. S.; Gayathri Aparna, N. Development and Validation of RP HPLC Method for Simultaneous Estimation of Netupitant and Palonosetron in Pharmaceutical Dosage Form. Int. J. Med. Pharm. Res. 2019, 7, 19–24.
   Google Scholar
• Surendra, P.; Prasanna, P. S.; Thejomoorthy, K. Development and Validation of New Analytical Method for The Simultaneous Estimation of Netupitant and Palonosetron in Pharmaceutical Dosage Form. Int. J. Pharm. Chem. 2021, 2, 50–59.
   Google Scholar
• Gandla, H.; Ajitha, M. Stability Indicating Method Development and Validation for Simultaneous Estimation of the Netupitant and Palonosetron in Bulk and Pharmaceutical Dosage Form by RP-HPLC. WJPS 2022, 113–120. DOI: 10.54037/WJPS.2022.100112.
   Google Scholar
• Rao, K. N.; Jayasri, R. D. M. Simultaneous Estimation of Netupitant and Palonosetron in Its Bulk and Pharmaceutical Dosage Form by RP-HPLC Method. Int. J. Chem. Pharm. Sci. 2018, 6, 285–290.
   Google Scholar
• Panigrahy, U. P.; Reddy, A. S. K. A Novel Validated RP-HPLC-DAD Method for the Simultaneous Estimation of Netupitant and Palonosetron in Bulk and Pharmaceutical Dosage form with Forced Degradation Studies. Int. J. Chem. Tech. Res. 2015, 8, 317–337.
   Google Scholar
• Bhagavanji, N.; Satyanarayana, P.; Sekhar, K.; Naniprasad, D. Development and Validation of Stability Indicating RP-HPLC Method for the Estimation of Netupitant and Palonosetron in Combined Tablet Dosage Form. Int. J. Pharm. Sci. Rev. Res. 2016, 41, 81–87.
   Google Scholar
• Chandar, P. B.; Madhuri, M. S.; Hyma, K. N.; Anusha, S.; Rasool, S. N. A RP-HPLC Stability Indicating Method Development and Validation for the Simultaneous Determination of Netupitant and Palonosetron in Pharmaceutical Dosage Form. Int. J. Curr. Pharm. Sci. 2022, 14, 60–67. DOI: 10.22159/ijcpr.2022v14i4.1985.
   Google Scholar
• Manoranjani, M. Method Development and Validation for Simultaneous Quantification of Netupitant and Palonosetron in Bulk and Pharmaceutical Dosage Form and Their Forced Degradation Study by RP-HPLC. Asian J. Pharm. Clin. Res. 2019, 12, 119–123. DOI: 10.22159/ajpcr.2019.v12i2.28949.
   Google Scholar
• Harole, M.; Patil, R. N.; Gaware, D.; Suryawanshi, G.; Pise, K. A Validated Stability Indicating Rp-HPLC Method for Simultaneous Determination of Netupitant and Palonosetron in Pharmaceutical Formulations. World Journal of Pharmacy and Pharmaceutical Sciences, 2016. 5, 2016, 878–887.
   Google Scholar
• Emmanue, K.; Kumar, D. P.; Subrahmanyam, T.; Murthy, B. S. Simple and Rapid RP-HPLC Method for Simultaneous Determination of Palonosetron and Netupitant in Spiked Human Plasma. JASR 2021, 12, 248–253.
   Google Scholar
• Nagamani, P.; Jayanthimala, S.; Mahesh, G.; Shanthi, N. Simultaneous Estimation of Netupitant and Palonosetron Using UPLC. Journal For Innovative Development in Pharmaceutical and Technical Science (JIDPTS) 2022, 5. 1–6.
   Google Scholar
• Kalavati, T.; Shyamala ; Sharma, J. V. C. Development and Validation of Stability Indicating UPLC Method for the Estimation of Palonosetron in Bulk and Its Pharmaceutical Dosage Form. Int. J. Pharm. Pharm. Res. 2019, 14, 144–154.
   Google Scholar
• Paladugu, N. D.; Wajid, S.; Satyanarayana, B.; Kumar, M. R. A New UPLC Method Development and Validation for Simultaneous Estimation of Netupitant and Palonosetron Using Bulk and Pharmaceutical Dosage Form Using UPLC. IJHS 2022, 6, 314–327. DOI: 10.53730/ijhs.v6nS6.9801.
   Google Scholar
• Xu, M.; Ni, Y.; Li, S.; Du, J.; Li, H.; Zhou, Y.; Li, W.; Chen, H. Development and Validation of a Rapid LC–MS/MS Method for Simultaneous Determination of Netupitant and Palonosetron in Human Plasma and Its Application to a Pharmacokinetic Study. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2016, 1027, 187–193. DOI: 10.1016/j.jchromb.2016.05.051.
   PubMed Web of Science ®Google Scholar
• Katkam, S.; Sagyam, R. R.; Sunkara, V.; Munagala, S.; Muttavarapu, M. M. EP2364312A2, European Patent Office, 2009.
   Google Scholar
• Flick, A. C.; Ding, H. X.; Leverett, C. A.; Kyne, R. E.; Liu, K. K.-C.; Fink, S. J.; O'Donnell, C. J. Synthetic Approaches to the New Drugs Approved during 2015. J. Med. Chem. 2017, 60, 6480–6515. DOI: 10.1021/acs.jmedchem.7b00010.
   PubMed Web of Science ®Google Scholar
• Ferreira, S. L.; Bruns, R. E.; Ferreira, H. S.; Matos, G. D.; David, J. M.; Brandão, G. C.; da Silva, E. G.; Portugal, L. A.; dos Reis, P. S.; Souza, A. S.; dos Santos, W. N. Box-Behnken Design: An Alternative for the Optimization of Analytical Methods. Anal. Chim. Acta 2007, 597, 179–186. DOI: 10.1016/j.aca.2007.07.011.
   PubMed Web of Science ®Google Scholar
• Zidan, A. S.; Sammour, O. A.; Hammad, M. A.; Megrab, N. A.; Habib, M. J.; Khan, M. A. Quality by Design: Understanding the Formulation Variables of a Cyclosporine a Self-Nanoemulsified Drug Delivery Systems by Box-Behnken Design and Desirability Function. Int. J. Pharm. 2007, 332, 55–63. DOI: 10.1016/j.ijpharm.2006.09.060.
   PubMed Web of Science ®Google Scholar
• Box, G. E. P.; Behnken, D. W. Some New Three Level Designs for the Study of Quantitative Variables. Technometrics 1960, 2, 455–475. DOI: 10.1080/00401706.1960.10489912.
   Google Scholar
• Govender, S.; Pillay, V.; Chetty, D. J.; Essack, S. Y.; Dangor, C. M.; Govender, T. Optimization and Characterization of Bio Adhesive Controlled Release Tetracycline Microspheres. Int. J. Pharm. 2005, 306, 24–40. DOI: 10.1016/j.ijpharm.2005.07.026.
   PubMed Web of Science ®Google Scholar
• Hassib, S. T.; Taha, E. A.; Sharf, M. G.; Mostafa, E. A. RP-HPLC-DAD Method Development and Validation for Simultaneous Determination of Lansoprazole, Tinidazole, Amoxicillin and Naproxen in Their Raw Materials and Combined Dosage Form. J. AOAC Int. 2022, 105, 675–687. DOI: 10.1093/jaoacint/qsab159.
   PubMed Web of Science ®Google Scholar
• International Conference on Harmonization (ICH). Validation of Analytical Procedures: Text and Methodology, Q2(R1), 2011. https://database.ich.org/sites/default/files/Q2%28R1% 29%20Guideline.pdf.
   Google Scholar